Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
20.03
-1.36 (-6.36%)
At close: Oct 6, 2026, 4:00 PM EDT
20.43
+0.40 (2.00%)
After-hours: Oct 6, 2026, 4:37 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $654.24 million as of October 6, 2026. Its market cap has increased by 327.97% in one year.
Market Cap
654.24M
Enterprise Value
632.08M
1-Year Change
327.97%
Ranking
Category
Stock Price
$20.03
ChartMarket Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $654.24M, an increase of 1,027.89%. That is a compound annual growth rate of 67.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 654.24M | 238.30% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 755.19M |
| Gyre Therapeutics | 753.90M |
| Achieve Life Sciences | 745.01M |
| Wave Life Sciences | 744.84M |
| Solid Biosciences | 734.49M |
| Faeth Therapeutics | 732.58M |
| Olema Pharmaceuticals | 719.67M |
| OmniAb | 708.05M |